Evidence map›Paper›PMID 35939522›Full record

ArticlePLoS pathogens2022

TMEM41B and VMP1 modulate cellular lipid and energy metabolism for facilitating dengue virus infection.

Meisam Yousefi, Wai Suet Lee, Biaoguo Yan, Liang Cui, Cythia Lingli Yong, Xin Yap, Kwan Sing Leona Tay, Wenjie Qiao, Dewei Tan, Nur Insyirah Nurazmi and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. The SMARCA4-TMEM47 axis plays an essential role in chikungunya virus RNA replication.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Dengue and severe dengue.Clinical microbiology reviews · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Meisam YousefiEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Wai Suet LeeEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Biaoguo YanEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Liang CuiAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore.
Cythia Lingli YongEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Xin YapEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Kwan Sing Leona TayAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore.
Wenjie QiaoDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, United States of America.
Dewei TanEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Nur Insyirah NurazmiEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Martin LinsterEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Gavin J D SmithEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Yie Hou LeeAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore.
Jan E CaretteDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, United States of America.
Eng Eong OoiEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Kuan Rong ChanEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.
Yaw Shin OoiEmerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore.ORCID 0000-0001-9014-1365
Duke-NUS Medical School · SGSingapore-MIT Alliance for Research and Technology · SGStanford University · USKK Women's and Children's Hospital · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transmembrane Protein 41B (TMEM41B) and Vacuole Membrane Protein 1 (VMP1) are two ER-associated lipid scramblases that play a role in autophagosome formation and cellular lipid metabolism. TMEM41B is also a recently validated host factor required by flaviviruses and coronaviruses. However, the exact underlying mechanism of TMEM41B in promoting viral infections remains an open question. Here, we validated that both TMEM41B and VMP1 are essential host dependency factors for all four serotypes of dengue virus (DENV) and human coronavirus OC43 (HCoV-OC43), but not chikungunya virus (CHIKV). While HCoV-OC43 failed to replicate entirely in both TMEM41B- and VMP1-deficient cells, we detected diminished levels of DENV infections in these cell lines, which were accompanied by upregulation of the innate immune dsRNA sensors, RIG-I and MDA5. Nonetheless, this upregulation did not correspondingly induce the downstream effector TBK1 activation and Interferon-beta expression. Despite low levels of DENV replication, classical DENV replication organelles were undetectable in the infected TMEM41B-deficient cells, suggesting that the upregulation of the dsRNA sensors is likely a consequence of aberrant viral replication rather than a causal factor for reduced DENV infection. Intriguingly, we uncovered that the inhibitory effect of TMEM41B deficiency on DENV replication, but not HCoV-OC43, can be partially reversed using exogenous fatty acid supplements. In contrast, VMP1 deficiency cannot be rescued using the metabolite treatment. In line with the observed phenotypes, we found that both TMEM41B- and VMP1-deficient cells harbor higher levels of compromised mitochondria, especially in VMP1 deficiency which results in severe dysregulations of mitochondrial beta-oxidation. Using a metabolomic profiling approach, we revealed distinctive global dysregulations of the cellular metabolome, particularly lipidome, in TMEM41B- and VMP1-deficient cells. Our findings highlight a central role for TMEM41B and VMP1 in modulating multiple cellular pathways, including lipid mobilization, mitochondrial beta-oxidation, and global metabolic regulations, to facilitate the replication of flaviviruses and coronaviruses.

Indexed as

CoronavirusCoronavirus InfectionsDengueEnergy MetabolismHumansLipidsMembrane ProteinsVirus ReplicationLipidsMembrane ProteinsVMP1 protein, human

Identifiers

PMID35939522
PMCPMC9387935
OpenAlexW4290667509

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.